People · Operator
Named in public records as an officer, director or promoter · active 2010–2018 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acadiasoft Inc | — | Other Technology | Series B | $57.7M | $722.1M | 2018 |
| BioExx Specialty Proteins Ltd. | — | Biotechnology | Seed | $9.7M | $101.4M | 2010 |
Joseph MacDonald at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph MacDonald on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Macdonald | 1 | 5 |
| Mark Stein | 1 | 5 |
| Christopher Walsh | 1 | 5 |
| Chris Schnarr | 1 | 4 |
| Paul Carter | 1 | 4 |
| Jeffrey Rosen | 1 | 3 |
| Will Ollerhead | 1 | 2 |
| Peter Lacey | 1 | 2 |
| Chris Carl | 1 | 2 |
| Scott Petersen | 1 | 2 |
| Nicholas Steele | 1 | 2 |
| Boudjema Fares | 1 | 1 |
| Tom Jessop | 1 | 1 |
| Kalpesh Ruparelia | 1 | 1 |
| Paul McClory | 1 | 1 |
| Kenneth Henriques | 1 | 1 |
| Steven Gibson | 1 | 1 |
| Kyla LaPierre | 1 | 1 |
| Andrew Challis | 1 | 1 |
| Howard Edelstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.